The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
The study is being done to try to determine which factors contribute to the persistence of HIV (how long the virus remains) in...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
